Loading clinical trials...
Loading clinical trials...
This trial is conducted globally. The aim of this clinical trial is to investigate the safety and pharmacokinetics (the determination of the concentration of the administered medication in blood over ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Novo Nordisk A/S
NCT06716814 · Haemophilia A (Moderate or Severe)
NCT06352216 · Haemophilia A, Synovitis, and more
NCT06831734 · Haemophilia A, Haemophilia B
NCT06285071 · Haemophilia A, Haemophilia B
NCT06752850 · Haemophilia A (Moderate or Severe), Hemophilia, Classic, and more
Novo Nordisk Investigational Site
Iowa City, Iowa
Novo Nordisk Investigational Site
Lexington, Kentucky
Novo Nordisk Investigational Site
Baltimore, Maryland
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions